Healthcare >> CEO Interviews >> September 14, 2001
Elliot F. Hahn, PhD , is President and a director of Andrx. From June
1990 to February 1993, Dr. Hahn was employed as Vice President,
Scientific Affairs of IVAX, where he was involved in the evaluation and
international licensing of product opportunities and was responsible for
maintaining the intellectual property of IVAX. From 1988 to 1993, Dr.
Hahn also served as the Vice President of Research of Baker Norton
Pharmaceuticals, a subsidiary of IVAX. Prior to that, he was an
Associate Professor at The Rockefeller University from 1977 to 1988.
From 1976 until 1978, Dr. Hahn was an Assistant Professor at Albert
Einstein College of Medicine and a member of the Institute for Steriod
Research at Montefiore Hospital in New York City. Since 1988, he has
been an adjunct Associate Professor at the University of Miami School of
Medicine. He currently serves on the board of several
pharmaceutical/medical companies. Dr. Hahn holds a BS degree from City
College scientific papers and is named as an inventor in a number of
United States patents. Profile
evolution of Andrx Corporation?
Dr. Hahn: Andrx was founded in late 1992 by Alan Cohen, our co-Chairman
and Chief Executive
